亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

無錫同創生物科技有限公司  

辣根過氧化物酶,5-溴-4氯-3吲哚-神經氨酸,吡咯酯等

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:張倩
  • 電話:13655185676
  • 郵件:wuxitongchuang@yahoo.cn
  • 傳真:0510-85899582
  • QQ:1760363918
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 2,2-聯氮基-雙-(3-乙基苯并噻唑啉-6-磺酸)二氨鹽
2,2-聯氮基-雙-(3-乙基苯并噻唑啉-6-磺酸)二氨鹽
單價 面議對比
詢價 暫無
發貨 江蘇無錫市付款后3天內
品牌 MRC
過期 長期有效
更新 2024-01-10 11:53
 
詳細信息

中文名稱:2,2-聯氮基-雙-(3-乙基苯并噻唑啉-6-磺酸)二氨鹽

英文名稱:Diammonium 2,2"-azino-bis(3-ethylbenzothiazoline-6-sulfonate)

CAS:30931-67-0

分子式:C18H24N6O6S4

分子量:548.68

規格:1G,5G,10G,50G,100G

等級:生化級

質量標準:

外觀:淺綠色粉末

E 0.001%/ 1cm, 340nm61725

溶解度:清澈,綠色。

薄層色譜:符合規定

干燥失重:3.0%

產品應用:游離氯的光譜試劑,酶免顯色底物,過氧化物酶的底物用于ELISA 步驟,該底物產生一種可溶性的顯綠色的終端產品可在405 nm處光譜讀取。這種反應可用1%SDS終止。

©2025 無錫同創生物科技有限公司 版權所有   技術支持:化工網   訪問量:36604  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |